{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:11:35Z","timestamp":1773796295340,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00417-024-06671-y","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T13:02:15Z","timestamp":1730379735000},"page":"901-908","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Submacular hemorrhage: My personal journey to the goal"],"prefix":"10.1007","volume":"263","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1565-8289","authenticated-orcid":false,"given":"Masahito","family":"Ohji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,31]]},"reference":[{"issue":"3","key":"6671_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0039-6257(97)00089-1","volume":"42","author":"MA Hochman","year":"1997","unstructured":"Hochman MA, Seery CM, Zarbin MA (1997) Pathophysiology and management of subretinal hemorrhage. Surv Ophthalmol 42(3):195\u2013213","journal-title":"Surv Ophthalmol"},{"issue":"9","key":"6671_CR2","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1097\/IAE.0b013e318287d99d","volume":"33","author":"M Fujikawa","year":"2013","unstructured":"Fujikawa M, Sawada O, Miyake T, Kakinoki M, Sawada T, Kawamura H, Sakaguchi H, Gomi F, Ohji M (2013) Comparison of pneumatic displacement for submacular hemorrhages with gas injection alone and gas plus tissue plasminogen activator. Retina 33(9):1908\u20131914","journal-title":"Retina"},{"issue":"1","key":"6671_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0002-9394(14)75575-8","volume":"109","author":"SR Bennett","year":"1990","unstructured":"Bennett SR, Folk JC, Blodi CF, Klugman M (1990) Factors prognostic of visual outcome in patients with subretinal hemorrhage. Am J Ophthalmol 109(1):33\u201337","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"6671_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00006982-199616030-00001","volume":"16","author":"RL Avery","year":"1996","unstructured":"Avery RL, Fekrat S, Hawkins BS, Bressler NM (1996) Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina 16(3):183\u2013189","journal-title":"Retina"},{"issue":"2","key":"6671_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000027400","volume":"213","author":"A Scupola","year":"1999","unstructured":"Scupola A, Coscas G, Soubrane G, Balestrazzi E (1999) Natural history of macular subretinal hemorrhage in age-related macular degeneration. Ophthalmologica 213(2):97\u2013102","journal-title":"Ophthalmologica"},{"issue":"2","key":"6671_CR6","first-page":"148","volume":"101","author":"K Saito","year":"1997","unstructured":"Saito K, Iijima H (1997) Visual prognosis and macular pathology in eyes with retinal macroaneurysms. Nippon Ganka Gakkai Zasshi 101(2):148\u2013151","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"6","key":"6671_CR7","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/0002-9394(82)90301-4","volume":"94","author":"H Glatt","year":"1982","unstructured":"Glatt H, Machemer R (1982) Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol 94(6):762\u2013773","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"6671_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0002-9394(14)71530-2","volume":"113","author":"CA Toth","year":"1992","unstructured":"Toth CA, Benner JD, Hjelmeland LM et al (1992) Ultramicrosurgical removal of subretinal hemorrhage in cats. Am J Ophthalmol 113(2):175\u2013182","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"6671_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0002-9394(88)90116-X","volume":"105","author":"E De Juan Jr","year":"1988","unstructured":"De Juan E Jr, Machemer R (1988) Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am J Ophthalmol 105(1):25\u201329","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"6671_CR10","first-page":"575","volume":"22","author":"GA Peyman","year":"1991","unstructured":"Peyman GA, Nelson NC, Alturki W et al (1991) Tissue plasminogen activating factor assisted removal of subretinal hemorrhage. Ophthalmic Surg 22(10):575\u2013582","journal-title":"Ophthalmic Surg"},{"issue":"5","key":"6671_CR11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0002-9394(14)76571-7","volume":"118","author":"H Lewis","year":"1994","unstructured":"Lewis H (1994) Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol 118(5):559\u2013568","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"6671_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/archopht.1995.01100010064022","volume":"113","author":"HE Ibanez","year":"1995","unstructured":"Ibanez HE, Williams DF, Thomas MA et al (1995) Surgical removal of submacular hemorrhage- A series of 47 consecutive cases. Arch Ophthalmol 113(1):62","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"6671_CR13","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/S0161-6420(95)30858-5","volume":"102","author":"JI Lim","year":"1995","unstructured":"Lim JI, Drews-Botsch C, Sternberg P Jr et al (1995) Submacular hemorrhage removal. Ophthalmology 102(9):1393\u20131399","journal-title":"Ophthalmology"},{"issue":"3","key":"6671_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0002-9394(14)70274-0","volume":"121","author":"M Kamei","year":"1996","unstructured":"Kamei M, Tano Y, Maeno T et al (1996) Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid. Am J Ophthalmol 121(3):267\u2013275","journal-title":"Am J Ophthalmol"},{"key":"6671_CR15","unstructured":"Herriot W (1996) Intravitreal gas and TPA: an outpatient procedure for subretinal hemorrhage. Vail Vitrectomy Meeting, 10\u00b115 March 96, Vail, Colorado."},{"issue":"10","key":"6671_CR16","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1001\/archopht.116.10.1326","volume":"116","author":"M Ohji","year":"1998","unstructured":"Ohji M, Saito Y, Hayashi A et al (1998) Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator. Arch Ophthalmol 116(10):1326\u20131332","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"6671_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s004170050232","volume":"237","author":"L Hesse","year":"1999","unstructured":"Hesse L, Schmidt J, Kroll P (1999) Management of acute submacular hemorrhage using recombinant plasminogen activator and gas. Graefe\u2019s Arch Clin Exp Ophthalmol 237(4):273\u2013277","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"issue":"10","key":"6671_CR18","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1016\/S0161-6420(99)90399-8","volume":"106","author":"AS Hassan","year":"1999","unstructured":"Hassan AS, Johnson MW, Schneiderman TE et al (1999) Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology 106(10):1900\u20131907","journal-title":"Ophthalmology"},{"issue":"8","key":"6671_CR19","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0161-6420(01)00648-0","volume":"108","author":"LO Hattenbach","year":"2001","unstructured":"Hattenbach LO, Klais C, Koch FJ et al (2001) Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions. Ophthalmology 108(8):1485\u20131492","journal-title":"Ophthalmology"},{"issue":"3","key":"6671_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/01.iae.0000237586.48231.75","volume":"27","author":"CY Chen","year":"2007","unstructured":"Chen CY, Hooper C, Chiu D et al (2007) Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas. Retina 27(3):321\u2013328","journal-title":"Retina"},{"issue":"3","key":"6671_CR21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/01.iae.0000231544.43093.40","volume":"27","author":"M Gopalakrishan","year":"2007","unstructured":"Gopalakrishan M, Giridhar A, Bhat S et al (2007) Pneumatic displacement of submacular hemorrhage: safety, efficacy and patient selection. Retina 27(3):329\u2013334","journal-title":"Retina"},{"issue":"4","key":"6671_CR22","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S0161-6420(02)01979-6","volume":"110","author":"SN Chen","year":"2003","unstructured":"Chen SN, Yang TC, Ho CL et al (2003) Retinal toxicity if intravitreal tissue plasminogen activator: case report and literature review. Ophthalmology 110(4):704\u2013708","journal-title":"Ophthalmology"},{"issue":"1","key":"6671_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000343066","volume":"229","author":"EJT van Zeeburg","year":"2013","unstructured":"van Zeeburg EJT, van Meurs JC (2013) Literature review of recombinant tissue plasminogen activator used for recent-Onset submacular hemorrhage displacement in age-related macular degeneration. Ophthalmologica 229(1):1\u201312","journal-title":"Ophthalmologica"},{"issue":"2","key":"6671_CR24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0002-9394(00)00734-0","volume":"131","author":"CL Haupert","year":"2001","unstructured":"Haupert CL, McCuen BW, Jaff GJ et al (2001) Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration. Am J Ophthalmol 131(2):208\u2013215","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"6671_CR25","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.ophtha.2003.10.020","volume":"111","author":"S Olivier","year":"2004","unstructured":"Olivier S, Chow DR, Packo KH et al (2004) Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement in age-related macular degeneration. Ophthalmology 111(6):1201\u20131208","journal-title":"Ophthalmology"},{"issue":"12","key":"6671_CR26","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1001\/jamaophthalmol.2013.5464","volume":"131","author":"JN Martel","year":"2013","unstructured":"Martel JN, Mahmound TH (2013) Subretinal pneumatic displacement of subretinal hemorrhage. JAMA Ophthalmol 131(12):1632\u20131635","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"6671_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00417-009-1158-7","volume":"248","author":"J Hillenkamp","year":"2010","unstructured":"Hillenkamp J, Surguch V, Framme C et al (2010) Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator. Graefes Arch Clin Exp Ophthalmol 248(1):5\u201311","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"6671_CR28","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1136\/bjophthalmol-2011-300655","volume":"96","author":"F Treumer","year":"2021","unstructured":"Treumer F, Roider J, Hillenkamp J (2021) Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular hemorrhage. Br J Ophthalmol 96:708\u2013713","journal-title":"Br J Ophthalmol"},{"key":"6671_CR29","unstructured":"Oshima Y, Ohji M, Tano Y. Pars plana vitrectomy with peripheral retinotomy following preoperative intravitreal tissue plasminogen activator: a modified procedure to drain massive subretinal hemorrhage. Br J Ophthalmol."},{"issue":"5","key":"6671_CR30","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1097\/IAE.0000000000000954","volume":"36","author":"JH de Jong","year":"2016","unstructured":"de Jong JH, van Zeeburg EJT, Cereda MG et al (2016) Intravitreal versus subretinal administration of recombinant tissue plasminogen activator combined with gas for acute submacular hemorrhages due to age-related macular degeneration- An exploratory prospective study. Retina 36(5):914\u2013925","journal-title":"Retina"},{"issue":"1","key":"6671_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/IAE.0000000000003294","volume":"42","author":"GWM Chew","year":"2022","unstructured":"Chew GWM, Ivanova T, Patton N et al (2022) Step-wise approach to the management of submacular hemorrhage using pneumatic displacement and vitrectomy. The Manchester Protocol. Retina 42(1):11\u201318","journal-title":"Retina"},{"issue":"6","key":"6671_CR32","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/s41433-019-0719-1","volume":"34","author":"JC van Meurs","year":"2020","unstructured":"van Meurs JC (2020) Many ways to displace a blood clot. But do we need to do so? Eye 34(6):997\u2013998","journal-title":"Eye"},{"issue":"1","key":"6671_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13063-021-05966-3","volume":"23","author":"TL Jackson","year":"2022","unstructured":"Jackson TL, Bunce C, Desai R et al (2022) Vitrectomy, subretinal tissue plasminogen activator and intravitreal gas for submacular hemorrhage secondary to exudative age-related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomized controlled surgical trials. Trials 23(1):99","journal-title":"Trials"},{"issue":"4","key":"6671_CR34","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0002-9394(02)02084-6","volume":"135","author":"A Tashimo","year":"2003","unstructured":"Tashimo A, Mitamura Y, Ohtsuka K et al (2003) Macular hole formation following ruptured retinal arterial macroaneurysm. Am J Ophthalmol 135(4):487\u2013492","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"6671_CR35","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1136\/bjo.2008.149195","volume":"93","author":"N Sagara","year":"2009","unstructured":"Sagara N, Kawaji T, Koshiyama Y et al (2009) Macular hole formation after macular hemorrhage associated with rupture of retinal arterial macroaneurysm. Br J Ophthalmol 93(10):1337\u20131340","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"6671_CR36","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00417-007-0724-0","volume":"246","author":"H Nakamura","year":"2008","unstructured":"Nakamura H, Hayakawa K, Sawaguchi S et al (2008) Visual outcome after vitreous, sub-internal limiting membrane, and\/or submacular hemorrhage removal associated with ruptured retinal arterial macroaneurysms. Graefes Arch Clin Exp Ophthalmol 246(5):661\u2013669","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"6671_CR37","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s00417-014-2861-6","volume":"253","author":"M Inoue","year":"2015","unstructured":"Inoue M, Shiraga F, Shirakata Y et al (2015) Subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage associated with ruptured retinal arterial macroaneurysm. Graefes Arch Clin Exp Ophthalmol 253(10):1663\u20131669","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"6671_CR38","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/IAE.0000000000003725","volume":"43","author":"S Doi","year":"2023","unstructured":"Doi S, Kimura S, Saito S et al (2023) Impact of macular intraretinal hemorrhage and macular hole on the visual prognosis of submacular hemorrhage due to retinal arterial macroaneurysm rupture. Retina 43(4):585\u2013593","journal-title":"Retina"},{"issue":"5","key":"6671_CR39","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1097\/IAE.0000000000001029","volume":"36","author":"T Okanouchi","year":"2016","unstructured":"Okanouchi T, Toshima S, Limura S et al (2016) Novel technique for subretinal injection using local removal of the internal limiting membrane. Retina 36(5):1035\u20131038","journal-title":"Retina"},{"issue":"9","key":"6671_CR40","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.3390\/jcm12093291","volume":"12","author":"A Kimura","year":"2023","unstructured":"Kimura A, Imai H, Iwane Y et al (2023) Removal of sub-internal limiting membrane hemorrhage secondary to retinal arterial macroaneurysm rupture: Internal limiting membrane non-peeling technique. J Clin Med 12(9):3291","journal-title":"J Clin Med"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06671-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-024-06671-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06671-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T15:03:00Z","timestamp":1747839780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-024-06671-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["6671"],"URL":"https:\/\/doi.org\/10.1007\/s00417-024-06671-y","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,31]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is not applied to this article because this article is a review article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Alcon Japan (F, R), Novartis (R), Otsuka Pharmaceutical (F, R), Santen Pharmaceutical (F, R), Senju Pharmaceutical (F, R), HOYA (F), Bayer (R), Chugai Pharmaceutical (F, C), AMO (F), Nikon\u00ae, Eyebell (F), Jonan Medical (F).F: Financial support, R: Recipient of honorarium, C: Consultant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This is not applied to this article because this article is a review article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving Human Participants and\/or Animals"}}]}}